Clinical trial
Antiplatelet Therapy to Prevent Stroke in African Americans
NCT00004727 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00004727 |
|---|---|
| Title | Antiplatelet Therapy to Prevent Stroke in African Americans |
| Official title | African American Antiplatelet Stroke Prevention Study |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Stroke, Cerebral Infarction |
| Intervention type | Drug |
| Interventions | aspirin, ticlopidine |
| First posted | Feb 28, 2000 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: